Phuar, H. L., Begley, C. E., Chan, W., & Krause, T. M. (2019). Tyrosine Kinase Inhibitors Initiation, Cost Sharing, and Health Care Utilization in Patients with Newly Diagnosed Chronic Myeloid Leukemia: A Retrospective Claims-Based Study. Journal of managed care & specialty pharmacy, 25(10), 1140-1150. https://doi.org/10.18553/jmcp.2019.25.10.1140
Chicago Style (17th ed.) CitationPhuar, Hsiao Ling, Charles E. Begley, Wenyaw Chan, and Trudy Millard Krause. "Tyrosine Kinase Inhibitors Initiation, Cost Sharing, and Health Care Utilization in Patients with Newly Diagnosed Chronic Myeloid Leukemia: A Retrospective Claims-Based Study." Journal of Managed Care & Specialty Pharmacy 25, no. 10 (2019): 1140-1150. https://doi.org/10.18553/jmcp.2019.25.10.1140.
MLA (9th ed.) CitationPhuar, Hsiao Ling, et al. "Tyrosine Kinase Inhibitors Initiation, Cost Sharing, and Health Care Utilization in Patients with Newly Diagnosed Chronic Myeloid Leukemia: A Retrospective Claims-Based Study." Journal of Managed Care & Specialty Pharmacy, vol. 25, no. 10, 2019, pp. 1140-1150, https://doi.org/10.18553/jmcp.2019.25.10.1140.